Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the effect of adding alogliptin, once daily (QD), to
the ongoing treatment regimen of pioglitazone HCl and metformin in patients with inadequate
glycemic control.